Abstract： Objective To evaluate the therapeutic effects and immunogenicity of Ag85A DNA vaccines in mouse models of M. tuberculosis infection to develop new immunotherapeutic agents for treatment of tuberculosis. Methods Fourty female BALB/c mice were immunized intramuscularly with saline, plasmid vector pVAX1, M.vaccae vaccine and Ag85A DNA for three times at two-week intervals to evaluate immunogenicity of Ag85A DNA vaccines.Fourty female BALB/c mice were infected intravenously via the tail vein with M. tuberculosis H37RV, then randomly divided into 4 groups based and treated as follow at the third day after infection：saline,plasmid vector,rifampin,Ag 85A plasmid DNA vaccines.DNA vaccines were injected intramuscularly 3 times at two-week intervals.Mice were sacrificed two weeks after the final immunization.The lungs and spleens from the mice were taken and their pathological changes, weight and number of mycobacterial colony were examined.ELISPOT assay for IFN-γ was performed with ELISPOT assay kit as instructed by the manufacture. Results Ag85A DNA vaccines had a significantly increased amount of T cells that secreted IFN-γ in response to Ag85A protein than mice treated with control groups（S=11.832，P=0.0080）.The histopathological changes in lung showed that the lung lesions were severe and extensive in saline and plasmid vector pVAX1 group, the lung lesions were slight and limited, there were relatively clear and normal structure of alveoli in Ag85A DNA vaccine group, there were no lung lesions in RFP group.Compared with saline group, Ag85A DNA vaccine group and RFP group reduced the pulmonary bacterial loads by 0.73 log and 2.11 log, liver bacterial loads by 0.88 log and 2.11 log (P<0.01), respectively. Conclusions The immunotherapeutic effects of Ag85A DNA are significant in the mouse model of tuberculosis.
World Health Organization. WHO report 2005- Global tuberculosis control: surveillance, lanning, Financing［J］. NZMed J,2006,119(1230):1175-1176.
［1］
World Health Organization. WHO report 2005- Global tuberculosis control: surveillance, lanning, Financing［J］. NZMed J,2006,119(1230):1175-1176.
[2]
吴雪琼,张俊仙,李洪敏,等.结核分枝杆菌Ag85A DNA 疫苗免疫治疗作用的研究［J］.中国免疫学杂志,2002,18(1):17-22.
[2]
吴雪琼,张俊仙,李洪敏,等.结核分枝杆菌Ag85A DNA 疫苗免疫治疗作用的研究［J］.中国免疫学杂志,2002,18(1):17-22.
[3]
Denis O , Tanghe A , Palfliet K, et al. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T cell epitopic repertoire broader than that stimulated by M. tuberculosis H37Rv infection［J］. Infect Immun,1998,6(4):1527-1533.
[4]
Huygen K, Content J, Denis O,et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine［J］. Nat Med, 1996,2(8):893-898.
[3]
Denis O , Tanghe A , Palfliet K, et al. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T cell epitopic repertoire broader than that stimulated by M. tuberculosis H37Rv infection［J］. Infect Immun,1998,6(4):1527-1533.
[4]
Huygen K, Content J, Denis O,et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine［J］. Nat Med, 1996,2(8):893-898.
[5]
Ha S J, Jeon B Y, Kim S C, et al. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis［J］. Gene Therapy, 2003,10(18):1592-1599.
[5]
Ha S J, Jeon B Y, Kim S C, et al. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis［J］. Gene Therapy, 2003,10(18):1592-1599.
[6]
Ha S J,Jeon B Y,Youn J I,et al.Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis［J］.Gene Therapy,2005,12(7):634-638.
[6]
Ha S J,Jeon B Y,Youn J I,et al.Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis［J］.Gene Therapy,2005,12(7):634-638.
[7]
Liang Y, Wu X Q, Zhang J X, et al.The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin［J］.Vaccine,2008,26(35):4536-4540.
[7]
Liang Y, Wu X Q, Zhang J X, et al.The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin［J］.Vaccine,2008,26(35):4536-4540.
[8]
Liang Y, Wu X, Zhang J, et al. Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs［J］.Scand J Immunol,2011,74(1):42-46.
[8]
Liang Y, Wu X, Zhang J, et al. Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs［J］.Scand J Immunol,2011,74(1):42-46.
[9]
Derrick S C, Repique C, Snoy P, et al.Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis［J］.Infect Immun,2004,72(3):1685-1692.
[9]
Derrick S C, Repique C, Snoy P, et al.Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis［J］.Infect Immun,2004,72(3):1685-1692.
2012, Vol. 23 
